Clinical trial
CIFN and IFN γ-1b With or Without Ribavirin for Treatment of Chronic Hepatitis C…
NCT00084279 · InterMune, Industry · Completed
Key facts
| NCT number | NCT00084279 |
|---|---|
| Title | CIFN and IFN γ-1b With or Without Ribavirin for Treatment of Chronic Hepatitis C (Nonresponders) |
| Official title | Safety and Tolerability of Consensus Interferon-Alpha (CIFN) Plus Interferon Gamma-1b (IFN-γ 1b) With or Without Ribavirin (RBV) in the Treatment of Patients With Chronic Hepatitis C Who Are Non-Responders to PEG-IFN-a (2a or 2b) Plus RBV |
| Lead sponsor | InterMune, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Chronic Hepatitis C |
| Intervention type | Drug |
| Interventions | Consensus Interferon-Alpha, Interferon Gamma-1b, Ribavirin |
| Enrollment | 81 |
| Start date | Apr 1, 2004 |
| Completion | Apr 1, 2006 |
| First posted | Jun 11, 2004 |
| Last update posted | Jul 3, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: